202 related articles for article (PubMed ID: 31875033)
1. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
Jones IC; Espindola MS; Narayanan R; Coelho AL; Habiel DM; Boehme SA; Ly TW; Bacon KB; Hogaboam CM
Sci Rep; 2019 Dec; 9(1):19796. PubMed ID: 31875033
[TBL] [Abstract][Full Text] [Related]
2. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
3. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
4. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
5. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
[TBL] [Abstract][Full Text] [Related]
6. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
[TBL] [Abstract][Full Text] [Related]
7. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
8. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
9. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
10. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
[TBL] [Abstract][Full Text] [Related]
11. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β.
Kottmann RM; Kulkarni AA; Smolnycki KA; Lyda E; Dahanayake T; Salibi R; Honnons S; Jones C; Isern NG; Hu JZ; Nathan SD; Grant G; Phipps RP; Sime PJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):740-51. PubMed ID: 22923663
[TBL] [Abstract][Full Text] [Related]
12. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
13. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
[TBL] [Abstract][Full Text] [Related]
15. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
17. The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.
Scruggs AM; Grabauskas G; Huang SK
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):191-203. PubMed ID: 31486669
[TBL] [Abstract][Full Text] [Related]
18. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
[TBL] [Abstract][Full Text] [Related]
19. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
